IIC
UTHR icon

Integrated Investment Consultants’s United Therapeutics UTHR Stock Holding History

Integrated Investment Consultants’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,146
Closed -$480K – 338
2025
Q3 		$480K Buy
1,146
+283
+33% +$95.2K 0.08% 151
2025
Q2 		$248K Hold
863
– – 0.05% 274
2025
Q1 		$266K Buy
+863
New +$296K 0.05% 269

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Integrated Investment Consultants's UTHR Position: Q4 2025 in Review

Integrated Investment Consultants sold out of United Therapeutics (UTHR) in Q4 2025, closing a stake of 1,146 shares — an estimated $480K sold.

Integrated Investment Consultants first reported a position in UTHR in Q1 2025 and held it in 3 quarters. The position peaked at $480K in Q3 2025. 838 funds tracked by Wall St. Rank hold UTHR as of Q4 2025.

  • Integrated Investment Consultants reported no remaining United Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Integrated Investment Consultants sold 1,146 United Therapeutics shares in Q4 2025, an estimated $480K.
  • Integrated Investment Consultants first reported a position in United Therapeutics in Q1 2025 and held it in 3 quarters.
  • Integrated Investment Consultants's United Therapeutics position peaked at $480K in Q3 2025.
  • 838 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2025.

Based on Integrated Investment Consultants's 13F filing for Q4 2025, filed 5 Feb 2026.